EPISODE · Jul 29, 2022 · 42 MIN
Fraud and Abuse: Advisory Opinion 22-14 and the Impact on Continuing Education Programs
from AHLA's Speaking of Health Law · host AHLA Podcasts
In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks with Jennifer Michael, Member, Bass Berry & Sims, about OIG Advisory Opinion 22-14, which was released on June 29 and analyzes an ophthalmology practice's proposal to offer continuing education (CE) programs for local optometrists. They discuss the requestor’s four proposals for financing the CE programs, OIG’s analysis and the questions it raises, and advice for the drug and device industry. Jennifer is the former Head of OIG’s Industry Guidance Branch. She co-authored a PG Briefing on this subject. From AHLA's Fraud and Abuse Practice Group. Sponsored by BRG.Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.
What this episode covers
In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks with Jennifer Michael, Member, Bass Berry & Sims, about OIG Advisory Opinion 22-14, which was released on June 29 and analyzes an ophthalmology practice's proposal to offer continuing education (CE) programs for local optometrists. They discuss the requestor’s four proposals for financing the CE programs, OIG’s analysis and the questions it raises, and advice for the drug a...
NOW PLAYING
Fraud and Abuse: Advisory Opinion 22-14 and the Impact on Continuing Education Programs
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m